Details:

Alternative Title:
Gynecol Oncol
Personal Author:
Froment, Marie-Anne ; Gomez, Scarlett L. ; Roux, Audrey ; DeRouen, Mindy C. ; Kidd, Elizabeth A. ;
Froment, Marie-Anne ; Gomez, Scarlett L. ; Roux, Audrey ; DeRouen, Mindy C. ; Kidd, Elizabeth A. ; Less -
Description:
Objective This study aimed to evaluate the incidence of cervical cancer by nativity [United States (US) versus non-US], neighborhood socioeconomic status and ethnic enclave among Hispanics and Asians in California. Methods Using data from the California Cancer Registry, information on all primary invasive cervical cancer (Cca) patients diagnosed in California from January 1, 1990 through December 31, 2004 was obtained. We analyzed the influence of enclave, socioeconomic status and nativity on Cca incidence. Results Among the 22,189 Cca cases diagnosed between 1990 and 2004, 50% were non-Hispanic white, 39% Hispanic and 11% Asian women, and 63% US-born. Seventy percent of the Cca cases were squamous cell carcinoma, 19% adenocarcinoma and 11% other histologies. Higher incidence of Cca was observed in high enclave (76%) and low socioeconomic status (70%) neighborhoods. By ethnic group, US-born women showed lower rates of squamous cell carcinoma compared to foreign-born women. Hispanics living in low socioeconomic and high enclave had 12.7 times higher rate of Cca than those living in high socioeconomic, low enclave neighborhoods. For Asian women incidence rates were 6 times higher in the low socioeconomic, high enclave neighborhoods compared to those living in high socioeconomic, low enclave neighborhoods. Conclusion More targeted outreach to increase Pap smear screening and human papilloma virus vaccination for women living in high enclave neighborhoods can help decrease the incidence of Cca in these groups of women.
Subject:
[+]
Adenocarcinoma
Adolescent
Adult
Asian Americans
Carcinoma, Squamous Cell
Female
Hispanic Americans
Humans
Incidence
Middle Aged
Residence Characteristics
Social Class
Uterine Cervical Neoplasms
Whites
Young Adult

Source:
Gynecol Oncol. 133(3):409-415. ;
Pubmed ID:
24674831
Pubmed Central ID:
PMC5746172
Document Type:
Journal Article ;
Funding:
HHSN261201000035C/PC,CA/None/None ; HHSN261201000140C/CA/NCI NIH HHS/United States ; U58 DP000807/DP/NCCDPHP CDC HHS/United States ; 1U58 DP000807-01/DP/NCCDPHP CDC HHS/United States ; HHSN261201000035I/CA/NCI NIH HHS/United States ; ... More +
HHSN261201000035C/PC,CA/None/None ; HHSN261201000140C/CA/NCI NIH HHS/United States ; U58 DP000807/DP/NCCDPHP CDC HHS/United States ; 1U58 DP000807-01/DP/NCCDPHP CDC HHS/United States ; HHSN261201000035I/CA/NCI NIH HHS/United States ; HHSN261201000034C/CA/NCI NIH HHS/United States ; N01 PC035137/PC/NCI NIH HHS/United States ; Less -
Place as Subject:
California ;
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:7046fd20282943fda2784a00e6364e542422e1fca6338d00b027a0ecb72ff84d
File Type:

Supporting Files

• 	NIHMS928966-supplement-Suppl_Data.pdf	pdf
  	nihms928966.nxml	xml
  	nihms928966f1.gif	gif
  	nihms928966f1.jpg	jpeg
  	nihms928966f2.gif	gif
  	nihms928966f2.jpg	jpeg

More +